UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine
Published: 2021-10-22 11:28:09 BdST
A medical worker holds a vial of AstraZeneca COVID-19 vaccine at a vaccination center, amid the coronavirus disease outbreak, in Ronquieres, Belgium Apr 6, 2021. REUTERS
The UK drug regulator added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome, or GBS, as a very rare side effect of the AstraZeneca COVID-19 vaccine, updates on the agency's website showed on Thursday.
Medicines and Healthcare products Regulatory Agency's decision comes after the European medicines agency added GBS as a possible side-effect last month.